[go: up one dir, main page]

PT3344758T - Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos - Google Patents

Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos

Info

Publication number
PT3344758T
PT3344758T PT167670447T PT16767044T PT3344758T PT 3344758 T PT3344758 T PT 3344758T PT 167670447 T PT167670447 T PT 167670447T PT 16767044 T PT16767044 T PT 16767044T PT 3344758 T PT3344758 T PT 3344758T
Authority
PT
Portugal
Prior art keywords
cell population
differentiating
pluripotent stem
vitro method
human pluripotent
Prior art date
Application number
PT167670447T
Other languages
English (en)
Original Assignee
Ncardia B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ncardia B V filed Critical Ncardia B V
Publication of PT3344758T publication Critical patent/PT3344758T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/375—Thyroid stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT167670447T 2015-09-01 2016-08-31 Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos PT3344758T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2015385 2015-09-01

Publications (1)

Publication Number Publication Date
PT3344758T true PT3344758T (pt) 2021-10-28

Family

ID=56117922

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167670447T PT3344758T (pt) 2015-09-01 2016-08-31 Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos

Country Status (8)

Country Link
US (2) US11136551B2 (pt)
EP (2) EP3964565A1 (pt)
DK (1) DK3344758T3 (pt)
ES (1) ES2895676T3 (pt)
HU (1) HUE057135T2 (pt)
PL (1) PL3344758T3 (pt)
PT (1) PT3344758T (pt)
WO (1) WO2017039445A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016131137A1 (en) 2015-02-17 2016-08-25 University Health Network Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes
NL2019618B1 (en) 2017-09-22 2019-03-28 Ncardia B V In vitro method for providing stem cell derived cardiomyocytes
CN108913655B (zh) * 2018-07-16 2022-07-15 浙江大学 基于多能干细胞技术建立“人源性”心肌肥大模型的方法
MX2021000614A (es) * 2018-07-17 2021-07-02 Univ California Células diferenciadas de células pluripotentes inmunodiseñadas.
CA3139072A1 (en) * 2019-05-03 2020-11-12 University Health Network Cardiomyocyte compositions and use thereof
US11162079B2 (en) 2019-05-10 2021-11-02 The Regents Of The University Of California Blood type O Rh-hypo-immunogenic pluripotent cells
WO2020231882A2 (en) 2019-05-10 2020-11-19 The Regents Of The University Of California Modified pluripotent cells
AU2023204829A1 (en) * 2022-01-10 2024-07-11 Sana Biotechnology, Inc. Hypoimmune beta cells differentiated from pluripotent stem cells and related uses and methods
WO2024004960A1 (ja) * 2022-06-27 2024-01-04 武田薬品工業株式会社 細胞の培養方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164370A (en) 1987-12-24 1992-11-17 Gropep Pty. Ltd. Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)
EP0429586B1 (en) 1989-06-09 1995-08-02 Gropep Pty. Ltd. Growth hormone fusion proteins
JP5098028B2 (ja) 2005-12-13 2012-12-12 国立大学法人京都大学 核初期化因子
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
UA103918C2 (en) 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
EP3255142A1 (en) 2009-10-19 2017-12-13 Cellular Dynamics International, Inc. Cardiomyocyte production
JP5930205B2 (ja) 2010-08-26 2016-06-08 国立大学法人京都大学 多能性幹細胞の心筋分化促進剤
RU2618871C2 (ru) 2011-06-09 2017-05-11 Ф. Хоффманн-Ля Рош Аг Способ дифференциации плюрипотентных стволовых клеток в клетки сосудистого русла
US9034584B2 (en) 2011-07-29 2015-05-19 Cellular Dynamics International, Inc. Metabolic maturation in stem cell-derived tissue cells
WO2013056072A1 (en) * 2011-10-13 2013-04-18 Wisconsin Alumni Research Foundation Generation of cardiomyocytes from human pluripotent stem cells
US9234176B2 (en) 2012-11-13 2016-01-12 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined production of cardiomyocytes from pluripotent stem cells
US9783550B2 (en) 2013-05-14 2017-10-10 The Board Of Regents Of The University Of Texas System Highly potent inhibitors of porcupine
ES2806698T3 (es) 2013-06-11 2021-02-18 Ncardia B V Composiciones de medio de cultivo para la maduración de cardiomiocitos derivados de células madre pluripotentes de mamíferos
ES2742444T3 (es) 2013-07-02 2020-02-14 Nat Univ Singapore Diferenciación de células madre pluripotentes y células progenitoras cardíacas en fibras de cardiomiocito estriadas usando laminianas LN-15, LN-521 y LN-221
WO2015040142A1 (en) * 2013-09-20 2015-03-26 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin A method to direct differentiation of pluripotent stem cells into functional heart muscle

Also Published As

Publication number Publication date
US20180251734A1 (en) 2018-09-06
PL3344758T3 (pl) 2022-01-03
US11136551B2 (en) 2021-10-05
EP3344758A1 (en) 2018-07-11
ES2895676T3 (es) 2022-02-22
WO2017039445A1 (en) 2017-03-09
HUE057135T2 (hu) 2022-04-28
EP3344758B1 (en) 2021-09-29
DK3344758T3 (da) 2021-11-01
US20220025333A1 (en) 2022-01-27
EP3964565A1 (en) 2022-03-09

Similar Documents

Publication Publication Date Title
PL3344758T3 (pl) Sposób in vitro różnicowania populacji ludzkich pluripotentnych komórek macierzystych w populację komórek kardiomiocytów
EP3344755A4 (en) PREPARATION SYSTEM FOR PLURIPOTENTE STEM CELLS AND METHOD FOR THE PRODUCTION OF INDUCED PLURIPOTENTAL STEM CELLS
EP3334820C0 (en) EXPANDED AND INDUCED PLURIPOTENT STEM CELLS, METHODS OF MANUFACTURE AND USE
SG11201603047PA (en) Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells
EP3272858A4 (en) Method for producing naïve pluripotent stem cells
EP3198004A4 (en) TGFß SIGNALING INDEPENDENT NAÏVE INDUCED PLURIPOTENT STEM CELLS, METHODS OF MAKING AND USE
SG11201609916RA (en) Culture method and cell mass
HK1220487A1 (zh) 全能幹細胞的誘導方法、及用該方法製備的全能幹細胞
EP3369809A4 (en) Method for obtaining leydig cells by carrying out induced differentiation on human induced pluripotent stem cells, and use of leydig cells
EP3196297A4 (en) Method for producing cardiomyocyte population from pluripotent stem cells
EP2949746A4 (en) METHOD OF SUB-CULTURE OF PLURIPOTENT STEM CELLS
IL254156A0 (en) Methods for producing neural stem cells and their use
EP3202896A4 (en) Method for culturing pluripotent stem cells
IL263557B (en) Differentiation of pluripotent stem cells into iris cells
SMT202000130T1 (it) Metodo di differenziazione di cellule staminali pluripotenti indotte da cellule staminali mesenchimali in neuroni
IL256093B (en) Method for multiplying and/or differentiating hematopoietic stem cells into progenitors and uses thereof
EP3088415A4 (en) Method for inducing differentiation of pluripotent stem cells into endodermal cells
IL252529B (en) Stem cell material and methods of preparation
EP3008174A4 (en) Method of efficiently establishing induced pluripotent stem cells
SG11201703600YA (en) Method of distinguishing mesenchymal stem cells
RS65645B1 (sr) Postupak za proizvodnju indukovanih pluripotentnih matičnih ćelija od adipoznih mezenhimalnih matičnih ćelija i indukovane pluripotentne matične ćelije proizvedene tim postupkom
HK1252090A1 (zh) 多能幹細胞製造系統和生產誘導多能幹細胞的方法
EP3500276A4 (en) METHOD FOR DIFFERENTIATING STEM CELLS IN ENDODERM
HK1254737A1 (zh) 幹細胞培養方法
EP3045531A4 (en) Method for inducing differentiation of induced pluripotent stem cells and method for selecting induced pluripotent stem cells